Macleods Pharmaceuticals has recalled one lot of the blood pressure medication Losartan after discovering trace amounts of a cancer-causing impurity in the product.
The tablets may contain N-nitrosodiethylamine, a probable human carcinogen.
The active drug ingredient was made at Hetero Labs in India, one of two drug manufacturers linked to a string of blood pressure medication recalls.
Macleods is the latest drugmaker to recall the blood pressure drug amid heightened safety concerns over the detection of the cancer-causing impurity. Major Pharmaceuticals, Teva Pharmaceuticals, Mylan and Aurobindo Pharma have also recalled blood pressure drugs in the last year.